Rockefeller Capital Management L.P. Inovio Pharmaceuticals, Inc. Transaction History

Rockefeller Capital Management L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.97 - $5.2 $891 - $1,560	-300 Reduced 28.57%	750 $2,000
Q4 2021 Feb 14, 2022	SELL	$4.99 - $7.46 $18,712 - $27,975	-3,750 Reduced 78.13%	1,050 $5,000
Q2 2021 Aug 10, 2021	SELL	$6.23 - $10.03 $485 - $782	-78 Reduced 1.6%	4,800 $44,000
Q1 2021 May 11, 2021	SELL	$8.81 - $16.96 $3,277 - $6,309	-372 Reduced 7.09%	4,878 $45,000
Q4 2020 Feb 12, 2021	BUY	$8.5 - $12.85 $17,000 - $25,700	2,000 Added 61.54%	5,250 $46,000
Q3 2020 Nov 13, 2020	SELL	$9.57 - $27.05 $35,887 - $101,437	-3,750 Reduced 53.57%	3,250 $37,000
Q2 2020 Aug 12, 2020	BUY	$7.14 - $31.69 $31,416 - $139,436	4,400 Added 169.23%	7,000 $189,000
Q1 2020 May 12, 2020	BUY	$2.98 - $14.09 $7,748 - $36,634	2,600 New	2,600 $19,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $496M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.